Institutional Ownership Cogent Biosciences, Inc. (COGT)
This table provides information about the institutional ownership of Cogent Biosciences, Inc. (COGT). We have compiled data on the 190 institutions that hold shares in the stock, with a total of 104 Million shares, which have been reported (via 13F filing form) to have a value of $754 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Kynam Capital Management, LP
Princeton, NJ |
Feb 14, 2025 Q4 2024 |
9,105,000
shares
|
$66 Million
4.5% of portfolio
|
Q4 2024
Reduced 1.46%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,288,378
shares
|
$52.8 Million
0.0% of portfolio
|
Q2 2024
Added 8.95%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
6,964,375
shares
|
$50.5 Million
8.87% of portfolio
|
Q2 2024
Added 12.07%
|
|
|
Commodore Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
6,881,629
shares
|
$49.9 Million
5.38% of portfolio
|
Q4 2024
Reduced 8.73%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
Feb 14, 2025 Q4 2024 |
6,225,641
shares
|
$45.1 Million
9.76% of portfolio
|
Q2 2024
Added 31.74%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
6,133,380
shares
|
$44.5 Million
0.0% of portfolio
|
Q4 2024
Added 7.33%
|
|
|
Vr Adviser, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
5,684,411
shares
|
$41.2 Million
7.32% of portfolio
|
Q4 2024
Added 0.0%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
5,347,302
shares
|
$38.8 Million
0.1% of portfolio
|
Q4 2024
Reduced 48.93%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
4,917,412
shares
|
$35.7 Million
1.46% of portfolio
|
Q4 2024
Added 6.67%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,300,000
shares
|
$31.2 Million
0.06% of portfolio
|
Q4 2024
Added 5.75%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,918,130
shares
|
$28.4 Million
0.0% of portfolio
|
Q4 2024
Added 21.25%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
3,554,836
shares
|
$25.8 Million
2.17% of portfolio
|
Q4 2024
Reduced 20.73%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,763,000
shares
|
$20 Million
4.81% of portfolio
|
Q4 2024
Added 111.72%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Feb 14, 2025 Q4 2024 |
2,631,000
shares
|
$19.1 Million
0.51% of portfolio
|
Q4 2024
Reduced 29.73%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,308,509
shares
|
$16.7 Million
0.0% of portfolio
|
Q4 2024
Added 1.22%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Feb 14, 2025 Q4 2024 |
1,498,425
shares
|
$10.9 Million
4.58% of portfolio
|
Q4 2024
Reduced 12.52%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
1,283,673
shares
|
$9.31 Million
0.0% of portfolio
|
Q4 2024
Added 28.35%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Feb 13, 2025 Q4 2024 |
1,122,471
shares
|
$8.14 Million
1.71% of portfolio
|
Q3 2024
Reduced 50.0%
|
|
|
Sg Americas Securities, LLC
|
Jan 17, 2025 Q4 2024 |
964,712
shares
|
$6.99 Million
0.03% of portfolio
|
Q4 2024
Added 2865.33%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
958,629
shares
|
$6.95 Million
0.0% of portfolio
|
Q4 2024
Added 39.15%
|
|
|
Walleye Capital LLC
Plymouth, MN |
Feb 13, 2025 Q4 2024 |
936,791
shares
|
$6.79 Million
0.02% of portfolio
|
Q4 2024
Added 68.09%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
936,576
shares
|
$6.79 Million
0.44% of portfolio
|
Q1 2024
Reduced 53.06%
|
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
921,137
shares
|
$6.68 Million
1.73% of portfolio
|
Q4 2024
Reduced 24.58%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
912,713
shares
|
$6.62 Million
0.0% of portfolio
|
Q4 2024
Added 7.72%
|
|
|
Superstring Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
910,865
shares
|
$6.6 Million
6.15% of portfolio
|
Q4 2024
New holding
|